Cover 2 Resources
Cover 2 Resources
Ep. 245 - Modern-day FDA, What’s New is Still Old
Ep. 245 - Modern-day FDA, What’s New is Still Old
Ep. 245 - Modern-day FDA, What’s New is Still Old
Thursday 6th June 2019
Dr. Raeford Brown discusses the FDA's role in the opioid crisis, examining decision-making and pharmaceutical influence. Listen now on Cover 2 Resources.
29 minutes
Informative
Thought-provoking
Raw
Insightful
Engaging
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Inside the FDA: Unpacking Its Role in the Opioid Crisis with Dr. Raeford Brown
The big problem with the FDA is that, whereas their mission is to protect the public health, their belief seems to be that their mission is to protect the profit margin of the pharmaceutical industry in regard to opioids...
Picture this: a former chair of the FDA's advisory committee sitting down to discuss the policies and decisions that fueled America's opioid crisis. In this eye-opening episode of Cover 2 Resources, host Greg McNeil dives into a candid conversation with Dr. Raeford Brown, who led the FDA's anesthetic and analgesic drug products advisory committee for five years. Dr. Brown doesn't shy away from tough topics, revealing the FDA's decision-making process, the sway of pharmaceutical companies, and the contentious REMS program.
The episode also revisits the Zohydro saga, shedding light on the agency's controversial approval decisions. Dr. Brown offers a rare insider perspective, questioning whether the FDA has truly learned from past mistakes or remains stuck in old ways. This episode is a must-listen for anyone wanting to understand the complexities behind regulatory decisions that have had far-reaching consequences. Tune in for a thought-provoking discussion that challenges the status quo and explores potential paths forward in addressing the opioid epidemic.